Related Experiment Videos
Hyperbaric Oxygen Therapy for Alzheimer's Disease.
1Neurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA.
EC Pharmacology and Toxicology
|September 15, 2018
Summary
Hyperbaric oxygen therapy (HBOT) shows promise for Alzheimer's disease (AD). However, potential risks like increased oxidative stress require careful clinical evaluation before widespread use in AD patients.
Area of Science:
- Neurology
- Hyperbaric Medicine
Background:
- Hyperbaric oxygen therapy (HBOT) is a recognized treatment for decompression illness.
- Emerging research suggests HBOT may offer therapeutic benefits for Alzheimer's disease (AD).
Purpose of the Study:
- To assess the potential of HBOT as a treatment for Alzheimer's disease.
- To evaluate the clinical risks and benefits of HBOT for AD patients, considering potential side effects.
Main Methods:
- Clinical assessment of HBOT efficacy and safety in Alzheimer's disease patients.
- Evaluation of oxidative stress markers associated with HBOT.
Main Results:
- HBOT demonstrates potential therapeutic effects for Alzheimer's disease.
- Concerns exist regarding oxygen toxicity and increased oxidative stress, necessitating further clinical investigation.
Conclusions:
- While HBOT presents a potential avenue for Alzheimer's disease treatment, its clinical application requires thorough risk-benefit analysis.
- Further clinical trials are essential to determine the safety and efficacy of HBOT for managing Alzheimer's disease.